Zimmer Biomet Holdings, Inc. (ZBH)
Makes artificial joints and surgical tools to repair broken bones and damaged knees and hips.
$95.94+0.04%Healthcare
StockGlow Score
Leaning Bullish
BearishBullish
1 year ago+5.9%
The outlook
ZBH trades at $95.94, sitting comfortably above both its 50- and 200-day moving averages and roughly midway through its 52-week range. Analyst consensus leans toward Buy, with the average price target around 3% above current levels. The stock carries a trailing P/E of 24.9, reflecting elevated valuations typical of medical device companies.
What’s behind the score
Analyst consensusBuy — 2.5 avg of 20 analysts
Price trendAbove its 50- & 200-day averages
52-week range58% of the way from its 52-week low to high
Price targetAvg target +3% vs current price
Analyst price target
~12-month · 20 analysts$98.60average target+2.8% vs now
Now $95.94
Low $83.00High $130.00
Published targets from Wall Street analysts (public data) — what analysts expect over roughly a year. This is not a StockGlow forecast and not a recommendation. Analyst targets are frequently wrong.
Market cap
$18.56B
52-wk high
$108.29
52-wk low
$79.12
50-day avg
$87.82
200-day avg
$91.13
Trailing P/E
24.9